|
Friday, 1st October, 1999 Lecture hall 3 Session 3: Drug Delivery Devices Chairmen: Paul Ashton (Boston), Frank Koch (Frankfurt/M) 13. Paul Ashton, K. Taba, D. R. Hinton, C. Puliafito, E. Reichel (Watertown / Los Angeles / Boston) Intravitreal substained release fluocinolone implant inhibits choroidal neovascularization. 14. Glenn J. Jaffe (Durham) Sustained Drug Delivery Systems. 15. Herrmann Guembel (Frankfurt/Main) Longterm follow-up (>2 years) of intraocular drug delivery devices. 16. Frank Koch (Frankfurt/Main) Grin-Endoscopy – longterm follow-up of Vitrasert. 17. Hilel Lewis, M. Kamei, P. K. Kaiser, T. Zhou, S. P. Schwendeman (Cleveland) A Continuously Released Multidrug Biodegradable Polymer Implant for Preventing Proliferative Vitreoretinopathy. Panel discussion Moderator: |